Uterine Fibroids Clinical Trial
Drexel Medicine is currently recruiting patients for a clinical trial to test a new procedure that relieves symptoms of uterine fibroids.
Uterine fibroids can lead to heavy menstrual bleeding, pain, fatigue and sometimes pregnancy loss. Mild symptoms can be helped with medication, but treatment options are limited for those suffering from abnormal bleeding that can be debilitating. A hysterectomy—a major surgery to remove the uterus—is sometimes the only option for women with severe symptoms. A less invasive procedure called endometrial ablation poses risks for women who wish to have children after surgery.
Dipak Delvadia, MD, and Minda Green, MD, of Drexel Obstetrics and Gynecology are testing a new, minimally invasive procedure to give women relief.
About the Sonata™ Study
The Sonata™ Study is for a system called Sonography-Guided Transcervical Ablation, also referred to as the Sonata™ System. Unlike surgery, the outpatient procedure accesses the uterus without any incisions, so there is no scarring and minimal recovery time. The system uses sonography to locate, target and shrink individual fibroids using heat.
Drexel Medicine is one of 25 medical sites throughout the country—and the only one in Eastern Pennsylvania—participating in the clinical study to test the new procedure. Delvadia successfully treated Philadelphia’s first participant in the study this fall, and Drexel Medicine is currently recruiting other patients.
Enroll in the Clinical Trial
For more information about participating in the clinical trial call 215.762.7442 or take a pre-screening questionnaire.
The images being used are for illustrative purposes only; any person depicted is a model.